Detalles de la búsqueda
1.
Pharmacokinetics and bioequivalence of two pomalidomide capsules in healthy chinese subjects under fasting and fed conditions.
Invest New Drugs
; 41(1): 60-69, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36441437
2.
Biochanin A as an α-hemolysin inhibitor for combating methicillin-resistant Staphylococcus aureus infection.
World J Microbiol Biotechnol
; 38(1): 6, 2021 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34837116
3.
Pharmacokinetics and safety of a new generic lurasidone: a phase I bioequivalence study in healthy Chinese subjects.
Naunyn Schmiedebergs Arch Pharmacol
; 2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38643450
4.
A randomized, single-blind, single-dose, parallel-group study in healthy subjects to demonstrate the pharmacokinetic equivalence of trastuzumab and its biosimilar.
Expert Opin Drug Metab Toxicol
; 19(11): 849-855, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37526387
5.
Pharmacokinetics and bioequivalence of sunitinib and Sutent® in Chinese healthy subjects: an open-label, randomized, crossover study.
Front Pharmacol
; 14: 1294688, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38026975
6.
Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects.
Expert Opin Investig Drugs
; 32(3): 263-270, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36757390
7.
A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif® in healthy Chinese subjects.
J Cancer Res Clin Oncol
; 149(6): 2585-2593, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35771264
8.
Comparing the bioequivalence and safety of liraglutide in healthy Chinese subjects: an open, single-dose, randomized, repeated, two-sequence, two-cycle phase I clinical trial.
Expert Rev Clin Pharmacol
; 16(4): 363-370, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883362
9.
Corrigendum: Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers.
Front Pharmacol
; 13: 907413, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35600852
10.
A randomized, double-blind, single-dose, two-way, parallel phase I clinical study comparing the pharmacokinetics and safety of adalimumab injecta and Humira® in healthy Chinese male volunteers.
Expert Opin Biol Ther
; 22(2): 225-234, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34134579
11.
Quercetin Reduces the Virulence of S. aureus by Targeting ClpP to Protect Mice from MRSA-Induced Lethal Pneumonia.
Microbiol Spectr
; 10(2): e0234021, 2022 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35319277
12.
A randomized, double-blind, single-dose, single-center, parallel phase I clinical study comparing the pharmacokinetics, immunogenicity, safety, and tolerance of pertuzumab injection and Perjeta® in healthy Chinese male subjects.
Expert Opin Biol Ther
; 22(2): 187-195, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34607519
13.
A randomized, double-blind, single-dose, parallel phase I clinical trial to compare the bioequivalence, immunogenicity, and safety of bevacizumab biosimilar and bevacizumab in healthy Chinese subjects.
Expert Opin Drug Metab Toxicol
; 18(7-8): 519-527, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35961948
14.
Pharmacokinetics and safety of the two oral cefaclor formulations in healthy chinese subjects in the fasting and postprandial states.
Front Pharmacol
; 13: 1012294, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36278160
15.
A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjects.
Int Immunopharmacol
; 109: 108780, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35461158
16.
A randomized, open-label, single-dose, two-cycle crossover study to evaluate the bioequivalence and safety of lenvatinib and Lenvima® in Chinese healthy subjects.
Expert Opin Investig Drugs
; 31(7): 737-746, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35427205
17.
Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers.
Front Pharmacol
; 12: 660541, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34149414
18.
Improved Antiviral Activity of Classical Swine Fever Virus-Targeted siRNA by Tetrahedral Framework Nucleic Acid-Enhanced Delivery.
ACS Appl Mater Interfaces
; 13(25): 29416-29423, 2021 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34148345
19.
Bioequivalence of two esomeprazole magnesium enteric-coated formulations in healthy Chinese subjects.
World J Clin Cases
; 8(22): 5518-5528, 2020 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33344542
20.
Correction to "Improved Antiviral Activity of Classical Swine Fever Virus-Targeted siRNA by Tetrahedral Framework Nucleic Acid-Enhanced Delivery".
ACS Appl Mater Interfaces
; 15(47): 55194, 2023 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37971869